articleNature BiotechnologyJan 17, 2010GREEN OA

Enhanced antibody half-life improves in vivo activity

JZJonathan ZalevskyAKAaron K. ChamberlainHMHolly M. HortonSKSher KarkiILIrene Leung

Xencor (United States) · Jackson Laboratory

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

640
total citations
FWCI
27.37
Percentile
100%
References
14
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Neonatal Fc receptor
  • In vivo
  • Antibody
  • Dosing
  • Genetically modified mouse
  • Transgene
  • Pharmacology
  • In vitro
No related works found for this paper.